Dr. Arie Slomianski, MD

Dr. Slomianski practices at Gastro Health in Miami, Florida.

Dr. Slomianski's NPI, 1376515973, was assigned on February 7, 2006. Dr. Slomianski graduated from Universidad Nacional Autonoma de Mexico in 1987. Dr. Slomianski holds Florida license ME78469.

Dr. Slomianski's primary practice is Gastro Health, at 15955 Sw 96th St, Miami, FL 33196 in Miami-Dade County. The practice phone is (305) 913-0666.

Dr. Slomianski's primary practice is Gastro Health in Miami, Florida. Dr. Slomianski is also affiliated with Baptist Health Baptist Hospital. The medical group on file is Gastro Health. Dmand AI also links Dr. Slomianski to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Slomianski practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Slomianski's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Slomianski is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Slomianski's licenses on file in 3 states: Florida, California and Michigan.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, fatty liver, gastroenteritis, gastrointestinal bleeding, hemorrhoids and intestinal diverticulosis among the conditions Dr. Slomianski treats.

CMS data shows 557 Medicare services from Dr. Slomianski across 10 procedure codes in 2024, for 258 Medicare patients. Medicare paid $55,528 for them.

CMS counts 258 Medicare patients who saw Dr. Slomianski in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Slomianski's median patient age at 64, with 56% women.

In 2024, Dr. Slomianski wrote 1,463 Medicare Part D claims for 470 patients. 84% of them were for generic drugs. CMS names the drug for 1,307 of them, across 22 drugs with 11 or more claims each, at $462,664 in total drug cost. In 2023, CMS named 1,050 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Slomianski for performance year 2024, reported as part of a group. Dr. Slomianski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Slomianski as offering telehealth. CMS counts 45 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Slomianski, more than 62% of the clinicians it reports for that procedure.

CMS Open Payments shows 184 general payments to Dr. Slomianski from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Bausch Health Americas, Inc. paid the most, $638.

Dr. Slomianski graduated from Universidad Nacional Autonoma de Mexico in 1987.

Dr. Slomianski is in network with 18 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.